R2 signs licensing agreement

Article

The University of Chicago is collaborating with R2 Technology on the development of a computer-aided detection mammography workstation, leveraging an investigational CAD reference library that contains a database of both malignant and benign lesions. The

The University of Chicago is collaborating with R2 Technology on the development of a computer-aided detection mammography workstation, leveraging an investigational CAD reference library that contains a database of both malignant and benign lesions. The reference library, which radiologists will be able to access for clinical comparison and relevancy, is being made available to R2 under an exclusive licensing agreement with the University of Chicago. This agreement is a natural extension of R2's existing collaboration with the university. The library may be the means for developing the next generation of CAD tools, according to Michael Klein, president and CEO of R2 Technology. The reference library workstation is designed to display and compare lesions the way most radiologists do in their own minds.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.